Joshi J Alumkal

23PUBLICATIONS
162CO-AUTHORS
Nanotoxicology, health and safetyMolecular targetsPredictive and prognostic markersCancer geneticsEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Aug 14, 2026
EZH2 Inhibition and Myeloid Risk: A Feature of On-Target Biology.

|Jan 05, 2026
Elevated Tumor-Associated Androgen Receptor Activity Correlates with Poor Immune Infiltration and Immunotherapy Response across Cancer Types.

Ya-Mei Hu, Faming Zhao, Julie N Graff

|Nov 26, 2025
Elevated tumor-associated androgen receptor activity correlates with poor immune infiltration and immunotherapy response across cancer types.

Ya-Mei Hu, Faming Zhao, Julie N Graff

|Sep 16, 2025
Multicenter Phase II Study of Olaparib and the ATR Inhibitor Ceralasertib in Metastatic Castration-Resistant Prostate Cancer (TRAP).

Irene Tsung, David C Smith, Elisabeth I Heath

|Aug 18, 2025
Divergent Clonal Evolution and Early Dissemination Promote Genetic Heterogeneity of Metastases in Castration-Resistant Prostate Cancer.

Noshad Hosseini, Rahul Mannan, Ryan J Rebernick

|Mar 31, 2025
Racial variation in the advanced prostate cancer genome.

Emily M Feng, Jenny Vo-Phamhi, Aishwarya N Subramanian

Pageof 4

Frequent Collaborators

6 joint publications

Rahul Aggarwal

6 joint publications

Martin Sjöström

6 joint publications

Zheng Xia

6 joint publications

Felix Y Feng